{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:01:32Z","timestamp":1761886892017,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.oftale.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:48:18Z","timestamp":1669290498000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Budget impact analysis of the XEN\u00ae63 for the treatment of primary openangle glaucoma in Spain"],"prefix":"10.1016","volume":"98","author":[{"given":"J.","family":"Vila Arteaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gutierrez D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Mart\u00ednez de la Casa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mill\u00e1 Gri\u00f1\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Asorey Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Salvador Alepuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"de Miguel Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Palomino Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ur\u00eda Mundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2022.11.002_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.ijg.0000133385.74502.29","article-title":"Prevalence of primary open-angle glaucoma in a Spanish population: The Segovia study","volume":"13","author":"Ant\u00f3n","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.oftale.2022.11.002_bib0010","series-title":"Terminology and guidelines for glaucoma","first-page":"172","author":"EGS","year":"2020"},{"key":"10.1016\/j.oftale.2022.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2022.11.002_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/jop.2008.0072","article-title":"The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: Changes in prescription patterns and patient persistence","volume":"25","author":"Zimmerman","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oftale.2022.11.002_bib0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertensionan evidence-based review","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2022.11.002_bib0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/eye.2008.103","article-title":"Barriers to adherence with glaucoma medications: a qualitative research study","volume":"23","author":"Lacey","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.oftale.2022.11.002_bib0035","first-page":"100:e327","article-title":"Microinvasive glaucoma surgery: a review and classification of implant\u2010dependent procedures and techniques","author":"Jab\u0142o\u0144ska","year":"2021","journal-title":"Acta Ophthalmolo"},{"key":"10.1016\/j.oftale.2022.11.002_bib0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ICU.0000000000000731","article-title":"Safety profile of minimally invasive glaucoma surgery","volume":"32","author":"Vinod","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/APO.0000000000000294","article-title":"Minimally invasive glaucoma surgery: Where is the evidence?","volume":"9","author":"Gillmann","year":"2020","journal-title":"Asia-Pacific J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2147\/OPTH.S135316","article-title":"Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents","volume":"11","author":"Pillunat","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/IJG.0b013e31825af67d","article-title":"Preservative exposure and surgical outcomes in glaucoma patients","volume":"22","author":"Boimer","year":"2013","journal-title":"J Glaucoma"},{"key":"10.1016\/j.oftale.2022.11.002_bib0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IIO.0000000000000234","article-title":"Role of cataract surgery in the management of glaucoma","volume":"58","author":"Ling","year":"2018","journal-title":"Int Ophthalmol Clin."},{"key":"10.1016\/j.oftale.2022.11.002_bib0065","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.18240\/ijo.2020.08.11","article-title":"Efficacy and safety of XEN 45 gel stent alone or in combination with phacoemulsification in advanced open angle glaucoma patients: 1-year retrospective study","volume":"45","author":"Laborda-Guirao","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000458494","article-title":"Management of concomitant cataract and glaucoma","volume":"59","author":"Marchini","year":"2017","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/OPX.0000000000001173","article-title":"The role of minimally invasive glaucoma surgery devices in the management of glaucoma","volume":"95","author":"Fingeret","year":"2018","journal-title":"Optom Vis Sci"},{"year":"2019","series-title":"Ficha t\u00e9cnica XEN63","author":"Allergan","key":"10.1016\/j.oftale.2022.11.002_bib0080"},{"key":"10.1016\/j.oftale.2022.11.002_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/ICU.0000000000000643","article-title":"Subconjunctival microinvasive glaucoma surgeries: an update on the Xen gel stent and the PreserFlo MicroShunt","volume":"31","author":"Do","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/4796548","article-title":"Comparing medium-term clinical outcomes following XEN\u00ae 45 and XEN\u00ae 63 device implantation","volume":"23","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0095","first-page":"350","article-title":"Cirug\u00eda filtrante de glaucoma v\u00eda ab interno con implante de col\u00e1geno XEN","volume":"5","author":"Lavin-Dapena","year":"2015","journal-title":"Revista Espa\u00f1ola de Glaucoma e Hipertensi\u00f3n Ocular"},{"key":"10.1016\/j.oftale.2022.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jcrs.2014.01.032","article-title":"Ab interno approach to the subconjunctival space using a collagen glaucoma stent","volume":"40","author":"Lewis","year":"2014","journal-title":"Cataract Refract Surg"},{"key":"10.1016\/j.oftale.2022.11.002_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","article-title":"Budget impact analysis\u2014principles of good practice: Report of the ISPOR 2012 budget impact analysis good practice II task force","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.oftale.2022.11.002_bib0110","first-page":"65","article-title":"Principios, m\u00e9todos y aplicaciones del an\u00e1lisis del impacto presupuestario en el sector sanitario","volume":"2","author":"Brosa","year":"2005","journal-title":"PharmacoEconomics"},{"year":"2021","series-title":"Demograf\u00eda y poblaci\u00f3n. Cifras de poblacion","author":"INE","key":"10.1016\/j.oftale.2022.11.002_bib0115"},{"key":"10.1016\/j.oftale.2022.11.002_bib0120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ophtha.2007.12.017","article-title":"Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002","volume":"115","author":"Stein","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2022.11.002_bib0125","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00417-013-2354-z","article-title":"Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: The CoGIS study in Germany","volume":"251","author":"Lorenz","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"year":"2021","series-title":"Datos internos","author":"Allergan","key":"10.1016\/j.oftale.2022.11.002_bib0130"},{"key":"10.1016\/j.oftale.2022.11.002_bib0135","article-title":"Estudio de mercado. An\u00e1lisis cuantitativo cirug\u00edas glaucoma en Espa\u00f1a","author":"Allergan","year":"2021","journal-title":"Datos internos"},{"key":"10.1016\/j.oftale.2022.11.002_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17469899.2018.1560264","article-title":"Budget impact analysis of the XEN\u00ae gel stent implant for glaucoma treatment","volume":"14","author":"Mart\u00ednez de la Casa","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"year":"2007","series-title":"Base de datos de costes sanitarios y ratios coste-efectividad espa\u00f1oles: eSalud","author":"Gisbert","key":"10.1016\/j.oftale.2022.11.002_bib0145"},{"key":"10.1016\/j.oftale.2022.11.002_bib0150","first-page":"523","article-title":"Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma","volume":"6","author":"Ting","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.oftale.2022.11.002_bib0155","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1185\/03007990802111068","article-title":"Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries","volume":"24","author":"Thygesen","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.oftale.2022.11.002_bib0160","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2005.067355","article-title":"Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe","volume":"89","author":"Traverso","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0165","first-page":"3202","article-title":"Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions","volume":"35","author":"Pereira","year":"2021","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.oftale.2022.11.002_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183142","article-title":"Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. Virgili G, editor","volume":"12","author":"Lavia","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.oftale.2022.11.002_bib0175","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1177\/1120672120952033","article-title":"XEN 63 gel stent device in glaucoma surgery: A 5-years follow-up prospective study","volume":"31","author":"Lavin-Dapena","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0180","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ceo.13463","article-title":"Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study","volume":"47","author":"Lenzhofer","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcjo.2017.10.005","article-title":"Surgeon perspectives on learning ab-interno gelatin microstent implantation","volume":"53","author":"Szigiato","year":"2018","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1120672118791937","article-title":"Referral for first glaucoma surgery in Europe, the ReF-GS study","volume":"29","author":"Holl\u00f3","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0195","first-page":"1941","article-title":"XEN\u00ae implant and trabeculectomy medium-term quality of life assessment and comparison of results","volume":"11","author":"Bas\u00edlio","year":"2018","journal-title":"Int J Ophthalmol"},{"year":"2021","series-title":"Minimally Invasive Glaucoma Surgery (MIGS) for individuals glaucoma. A health technology assessment","author":"Lund","key":"10.1016\/j.oftale.2022.11.002_bib0200"},{"key":"10.1016\/j.oftale.2022.11.002_bib0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/IJG.0000000000001107","article-title":"Glaucoma gel implant learning curve in a teaching tertiary hospital","volume":"28","author":"Marques","year":"2019","journal-title":"J Glaucoma"},{"key":"10.1016\/j.oftale.2022.11.002_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5575445","article-title":"Surgical and perioperative considerations for the treatment of cataract in eyes with glaucoma: A literature review","volume":"26","author":"Tsakiris","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0215","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10792-020-01314-7","article-title":"Comparative efficacy and cost\u2013utility of combined cataract and minimally invasive glaucoma surgery in primary open-angle glaucoma","volume":"40","author":"Bartelt-Hofer","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftale.2022.11.002_bib0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40123-018-0131-0","article-title":"Systematic literature review of clinical and economic outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in primary open-angle glaucoma","volume":"7","author":"Agrawal","year":"2018","journal-title":"Ophthalmol Ther"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579422001748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579422001748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:29:02Z","timestamp":1761881342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579422001748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2173579422001748"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2022.11.002","relation":{},"ISSN":["2173-5794"],"issn-type":[{"type":"print","value":"2173-5794"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Budget impact analysis of the XEN\u00ae63 for the treatment of primary openangle glaucoma in Spain","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2022.09.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}